NCT01248949 arm group 9a66ebbe89b3b554c2c57ba41b326aab [clinicaltrials_resource:NCT01248949/arm-group/9a66ebbe89b3b554c2c57ba41b326aab]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01248949 arm group 9a66ebbe89b3b554c2c57ba41b326aab [clinicaltrials_resource:NCT01248949/arm-group/9a66ebbe89b3b554c2c57ba41b326aab]
Bio2RDF identifier
NCT01248949/arm-group/9a66ebbe89b3b554c2c57ba41b326aab
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 66ebbe89b3b554c2c57ba41b326aab
description [clinicaltrials_vocabulary:description]
1 of 4 doses of MEDI3617 with ...... m could enroll 12-24 subjects.
identifier
clinicaltrials_resource:NCT01248949/arm-group/9a66ebbe89b3b554c2c57ba41b326aab
title
NCT01248949 arm group 9a66ebbe89b3b554c2c57ba41b326aab
@en
type
label
NCT01248949 arm group 9a66ebbe ...... 6ebbe89b3b554c2c57ba41b326aab]
@en